SEC Form D · Amendment · filed November 2, 2017
Medicinal Genomics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Richard T. Mckernan · Vero Beach, FLDirectorPhilip J. Chapman · New York, NYDirectorCharles M. Farkas · Woburn, MADirectorMark H. Deblois · Boston, MADirectorRichard T. Upton · Woburn, MADirectorBrendan L. Mckernan · Charlestown, MAExec · DirectorPatrick J. Costello · Woburn, MAExecKevin J. Mckernan · Woburn, MAExecGeoff Radcliffe · Luxembourg, LuxembourgExecCharles C. Hibben · Lakewood, CODirectorAndre J. Bourbonnais · New York, NYExec · DirectorHugo Neuman · Luxembourg, LuxembourgDirectorBrad Farber · New York, NYDirectorJ. J. Assaf · Los Angeles, CAExecCormac Sheehan · Grand Cayman, Cayman IslandsDirectorAudrey J. Lewis · Scheidgen, LuxembourgDirectorJerome C. Silvey · Greenwich, CTDirectorLanhee Yung · Greenwich, CTDirectorMichael Lefton · Greenwich, CTDirectorAnson Hwang · Tulsa, OKDirectorCurtis L. Crofford · Dallas, TXDirectorAxel Capital Management, LLC · New York, NYExec · DirectorAxel Capital, LLC · New York, NYExecKenneth A. Cowin · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗